ResearcherNantong UniversityActive in the last 2 years

Pengcheng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1477-0586; OpenAlex author ID A5050367926, A5130592718. Sources: OpenAlex.

Their work

Papers: 5 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 5

CAFs-derived LAM332 promotes CTCs formation and survival via ITGA3 and contributes to the metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-026-08642-z ↗
Identifying ARRB2 as a Prognostic Biomarker and Key Player in the Tumor Microenvironment of Pancreatic Cancer through scPagwas Methodology. Co-author DOI 10.2174/0115665232427614250904061700 ↗
Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for Pancreatic Cancer Treatment. Co-author DOI 10.34133/bmr.0050 ↗
COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation. Last author DOI 10.3390/cancers15051480 ↗
miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. Co-author DOI 10.1007/s00066-020-01728-3 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuhua Lu · 2 shared papers, 2021–2023 · strength 0.36
- Paper COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bi… DOI 10.3390/cancers15051480 ↗
- Paper miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. DOI 10.1007/s00066-020-01728-3 ↗
Yewei Zhang · 1 shared paper, 2024 · strength 0.28
- Paper Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for P… DOI 10.34133/bmr.0050 ↗
Fangfang Hu · 1 shared paper, 2026 · strength 0.28
- Paper CAFs-derived LAM332 promotes CTCs formation and survival via ITGA3 and contributes to the metastasis of pancreatic duct… DOI 10.1038/s41419-026-08642-z ↗
Haodong Tang · 1 shared paper, 2026 · strength 0.28
- Paper CAFs-derived LAM332 promotes CTCs formation and survival via ITGA3 and contributes to the metastasis of pancreatic duct… DOI 10.1038/s41419-026-08642-z ↗
Jiahua Zhou · 1 shared paper, 2026 · strength 0.28
- Paper CAFs-derived LAM332 promotes CTCs formation and survival via ITGA3 and contributes to the metastasis of pancreatic duct… DOI 10.1038/s41419-026-08642-z ↗
Lei Wang · 1 shared paper, 2026 · strength 0.26
- Paper Identifying ARRB2 as a Prognostic Biomarker and Key Player in the Tumor Microenvironment of Pancreatic Cancer through s… DOI 10.2174/0115665232427614250904061700 ↗
Gaonan Tian · 1 shared paper, 2026 · strength 0.26
- Paper Identifying ARRB2 as a Prognostic Biomarker and Key Player in the Tumor Microenvironment of Pancreatic Cancer through s… DOI 10.2174/0115665232427614250904061700 ↗
Lei Wang · 1 shared paper, 2023 · strength 0.24
- Paper COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bi… DOI 10.3390/cancers15051480 ↗
Yao Hua Song · 1 shared paper, 2023 · strength 0.24
- Paper COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bi… DOI 10.3390/cancers15051480 ↗
Zhiwei Wang · 1 shared paper, 2021 · strength 0.12
- Paper miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. DOI 10.1007/s00066-020-01728-3 ↗
Lei Wang · 1 shared paper, 2021 · strength 0.12
- Paper miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. DOI 10.1007/s00066-020-01728-3 ↗
Mingyan Zhu · 1 shared paper, 2021 · strength 0.12
- Paper miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. DOI 10.1007/s00066-020-01728-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.